🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/05/2025 15,81 17,19 15,55 16,82 +8,10% 10,40% 3.066.000
28/05/2025 15,50 15,98 15,35 15,56 +1,24% 4,06% 1.541.200
27/05/2025 15,62 15,68 15,22 15,37 +1,59% 2,94% 1.282.900
23/05/2025 15,08 15,37 14,92 15,13 -1,69% 2,95% 1.230.400
22/05/2025 15,24 15,59 15,02 15,39 +0,52% 3,77% 1.474.000
21/05/2025 16,25 16,47 15,17 15,31 -6,02% 8,00% 1.893.600
20/05/2025 15,86 16,32 15,62 16,29 +3,49% 4,41% 1.940.700
19/05/2025 15,29 15,99 15,21 15,74 +0,19% 5,10% 1.897.000
16/05/2025 15,37 15,85 15,19 15,71 +2,41% 4,29% 1.822.700
15/05/2025 14,91 15,40 14,68 15,34 +2,88% 4,80% 2.143.700
14/05/2025 15,28 16,03 14,79 14,91 -2,42% 8,12% 2.444.500
13/05/2025 15,75 16,83 14,77 15,28 +9,38% 13,08% 4.491.700
12/05/2025 13,87 14,40 13,42 13,97 +7,21% 7,07% 2.097.400
09/05/2025 13,26 13,98 12,89 13,03 -1,66% 8,26% 1.253.000
08/05/2025 13,06 13,49 12,44 13,25 +1,45% 8,04% 1.285.300
07/05/2025 13,14 13,26 12,82 13,06 -0,15% 3,35% 1.073.300
06/05/2025 13,75 13,90 12,83 13,08 -6,44% 7,78% 2.241.600
05/05/2025 14,33 14,40 13,97 13,98 -3,05% 3,00% 883.900
02/05/2025 14,23 14,97 14,22 14,42 +2,71% 5,27% 1.397.100
01/05/2025 13,89 14,25 13,43 14,04 +1,08% 5,90% 1.233.800
30/04/2025 13,12 14,24 13,00 13,89 +3,12% 9,45% 1.674.300
29/04/2025 13,49 13,83 13,29 13,47 -0,37% 3,97% 1.112.800
28/04/2025 13,38 13,85 13,36 13,52 +2,04% 3,66% 1.051.200
25/04/2025 13,12 13,43 12,90 13,25 -0,67% 4,04% 862.700
24/04/2025 13,13 13,40 12,81 13,34 +2,54% 4,49% 1.035.000
23/04/2025 12,88 13,45 12,76 13,01 +5,26% 5,40% 1.753.900
22/04/2025 12,21 12,51 11,89 12,36 +2,32% 5,06% 1.748.400
21/04/2025 11,04 12,50 10,95 12,08 +7,47% 14,04% 2.521.300
17/04/2025 11,27 11,51 10,92 11,24 -0,97% 5,19% 2.384.200
16/04/2025 12,75 12,75 11,00 11,35 -11,81% 13,73% 3.772.700